Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BMPER | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | DOT1L | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
mRNA | KIAA1614 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | BOLA2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | TRMT10A | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | KRTAP12-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | PLEKHG2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | ELL3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | TOR4A | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | AGO3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |